Brief: Sandu Pharmaceuticals - Approved Conversion Of 2nd Tranche Of Warrants Into Equity
02/03/2022 11:28
March 2 (Reuters) - Sandu Pharmaceuticals Ltd SAPH.BO :
* SANDU PHARMACEUTICALS LTD - APPROVED CONVERSION OF 2ND
TRANCHE
OF WARRANTS INTO EQUITY SHARES AT 20.69 RUPEES PER SHARE
Source text for Eikon: ID:nBSE1TSM2K
Further company coverage: SAPH.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sandu Pharmaceuticals
See all newsBrief: Sandu Pharmaceuticals Says Rakesh Parekh Resigns From Post Of CFO
Brief: Sandu Pharmaceuticals - Approved Conversion Of 2nd Tranche Of Warrants Into Equity
Brief: Sandu Pharma Resumes Manufacturing Ops At Pilerne Industrial Estate After Fire Incident
Brief: Sandu Pharma Resumes 40% Manufacturing Operations At Pilerne Industrial Estate, Goa After Fire Incident
Brief: Sandu Pharmaceuticals Reports Fire Accident At Factory Due To Effects Of Tauktae Cyclone In Goa